Department of Head and Neck Surgery, Gustave Roussy Institut, 39 rue Camille Desmoulins, 94805 Villejuif, France.
Oral Oncol. 2011 Jul;47(7):631-5. doi: 10.1016/j.oraloncology.2011.04.019. Epub 2011 Jun 8.
Head and neck squamous cell carcinomas are common lesions, related to chronic smoking and drinking behaviors. But in contrast to other cancers, effect of obesity on occurrence, diagnosis, treatment and prognosis of these tumors remains to date unknown. This is a retrospective review of 111 obese patients (sex ratio=6.4, median age=54.5 year old), treated between 1999 and 2007. Risk factors, tumoral localization and staging (41% stage I-II) were the same as in general population. However, we found 26.1% difficult pan-endoscopies, 54% ACE-27 comorbidity scores ≥2 and 22.5% misstaged cervical lymphadenopathy. Treatment was based upon surgery (61%) or radiotherapy-chemotherapy (39%), and 37% of patients developed complications. Median follow up (38 months) and five-year overall survival (50%) are comparable to data in non obese patients. Although no direct relation between obesity and squamous cell carcinomas of the head and neck was found, obesity causes problems in tumor assessment and increases surgical complications rate. However, final good therapeutic tolerance and overall survival rate show that these patients should be managed like normal weighted ones. Receiving optimal treatments allow them to anticipate equivalent outcome as in general population.
头颈部鳞状细胞癌是一种常见的病变,与慢性吸烟和饮酒行为有关。但与其他癌症不同,肥胖对这些肿瘤的发生、诊断、治疗和预后的影响至今仍不清楚。这是对 111 例肥胖患者(性别比=6.4,中位年龄=54.5 岁)进行的回顾性研究,这些患者的治疗时间在 1999 年至 2007 年之间。这些患者的危险因素、肿瘤定位和分期(41%为 I-II 期)与一般人群相同。然而,我们发现 26.1%的患者内镜检查困难,54%的患者 ACE-27 合并症评分≥2,22.5%的患者颈部淋巴结转移分期错误。治疗方法基于手术(61%)或放化疗(39%),37%的患者出现并发症。中位随访(38 个月)和 5 年总生存率(50%)与非肥胖患者的数据相当。尽管肥胖与头颈部鳞状细胞癌之间没有直接关系,但肥胖会导致肿瘤评估出现问题,并增加手术并发症的发生率。然而,良好的治疗耐受性和总体生存率表明,这些患者的治疗应与体重正常的患者相同。接受最佳治疗可以使他们获得与一般人群相当的预期结果。